Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

World Heart Federation Roadmap for Heart Failure.

Ferreira JP, Kraus S, Mitchell S, Perel P, Piñeiro D, Chioncel O, Colque R, de Boer RA, Gomez-Mesa JE, Grancelli H, Lam CSP, Martinez-Rubio A, McMurray JJV, Mebazaa A, Panjrath G, Piña IL, Sani M, Sim D, Walsh M, Yancy C, Zannad F, Sliwa K.

Glob Heart. 2019 Sep;14(3):197-214. doi: 10.1016/j.gheart.2019.07.004. No abstract available.

PMID:
31451235
2.

Non-communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies.

Mudie K, Jin MM, Tan, Kendall L, Addo J, Dos-Santos-Silva I, Quint J, Smeeth L, Cook S, Nitsch D, Natamba B, Gomez-Olive FX, Ako A, Perel P.

J Glob Health. 2019 Dec;9(2):020409. doi: 10.7189/jogh.09.020409. Review.

3.

Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon.

Boulle P, Sibourd-Baudry A, Ansbro É, Prieto Merino D, Saleh N, Zeidan RK, Perel P.

Confl Health. 2019 Aug 9;13:37. doi: 10.1186/s13031-019-0217-x. eCollection 2019.

4.

Access to Essential Medicines for Circulatory Diseases: A Call to Action.

McKee M, Scarlatescu O, Wood D, Eiselé JL, Perel P, Yusuf S.

Glob Heart. 2019 Aug 2. pii: S2211-8160(19)30121-8. doi: 10.1016/j.gheart.2019.07.008. [Epub ahead of print] No abstract available.

PMID:
31383576
5.

The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data.

Sinnott SJ, Smeeth L, Williamson E, Perel P, Nitsch D, Tomlinson LA, Douglas IJ.

Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1267-1277. doi: 10.1002/pds.4808. Epub 2019 Jul 16.

6.

Forty years since Alma-Ata: do we need a new model for noncommunicable diseases?

Beran D, Perel P, Miranda JJ.

J Glob Health. 2019 Jun;9(1):010316. doi: 10.7189/jogh.09.010316. Review. No abstract available.

7.

Response by Prabhakaran et al to Letter Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial".

Prabhakaran D, Jha D, Ajay VS, Roy A, Perel P.

Circulation. 2019 Jun 11;139(24):e1039. doi: 10.1161/CIRCULATIONAHA.119.040782. Epub 2019 Jun 10. No abstract available.

PMID:
31180750
8.

At the heart of the conflict.

Ansbro É, Perel P.

Heart. 2019 Sep;105(18):1382-1383. doi: 10.1136/heartjnl-2019-315010. Epub 2019 Jun 1. No abstract available.

9.

User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method Study.

Haldane V, Koh JJK, Srivastava A, Teo KWQ, Tan YG, Cheng RX, Yap YC, Ong PS, Van Dam RM, Foo JM, Müller-Riemenschneider F, Koh GC, Foong PS, Perel P, Legido-Quigley H.

JMIR Mhealth Uhealth. 2019 May 28;7(5):e10465. doi: 10.2196/10465.

10.

Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review.

Carrillo-Larco RM, Altez-Fernandez C, Pacheco-Barrios N, Bambs C, Irazola V, Miranda JJ, Danaei G, Perel P.

Glob Heart. 2019 Mar;14(1):81-93. doi: 10.1016/j.gheart.2019.03.001.

11.

Can a nurse-led community-based model of hypertension care improve hypertension control in Ghana? Results from the ComHIP cohort study.

Adler AJ, Laar A, Prieto-Merino D, Der RMM, Mangortey D, Dirks R, Lamptey P, Perel P.

BMJ Open. 2019 Apr 2;9(4):e026799. doi: 10.1136/bmjopen-2018-026799.

12.

The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries.

Kehlenbrink S, Smith J, Ansbro É, Fuhr DC, Cheung A, Ratnayake R, Boulle P, Jobanputra K, Perel P, Roberts B.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):638-647. doi: 10.1016/S2213-8587(19)30082-8. Epub 2019 Mar 14. Review.

PMID:
30878268
13.

Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods Study.

Haldane V, Tan YG, Teo KWQ, Koh JJK, Srivastava A, Cheng RX, Yap YC, Ong PS, van Dam RM, Foo JM, Müller-Riemenschneider F, Koh GC, Perel P, Legido-Quigley H.

JMIR Mhealth Uhealth. 2019 Mar 14;7(3):e11108. doi: 10.2196/11108.

14.

Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial.

Prabhakaran D, Jha D, Prieto-Merino D, Roy A, Singh K, Ajay VS, Jindal D, Gupta P, Kondal D, Goenka S, Jacob PD, Singh R, Prakash Kumar BG, Perel P, Tandon N, Patel V.

Circulation. 2018 Nov 10. doi: 10.1161/CIRCULATIONAHA.118.038192. [Epub ahead of print]

15.

Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study.

Koh JJK, Cheng RX, Yap Y, Haldane V, Tan YG, Teo KWQ, Srivastava A, Ong PS, Perel P, Legido-Quigley H.

Patient Prefer Adherence. 2018 Nov 22;12:2481-2498. doi: 10.2147/PPA.S176256. eCollection 2018.

16.

Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology.

Sosa-Liprandi Á, Sosa Liprandi MI, Alexánderson E, Avezum Á, Lanas F, López-Jaramillo JP, Martínez F, Ponte-Negretti N CI, Wyss F, González Juanatey JR, Perel P.

Glob Heart. 2019 Mar;14(1):3-16.e1. doi: 10.1016/j.gheart.2018.10.001. Epub 2018 Nov 28. Review.

PMID:
30502220
17.

Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.

Thomas H, Diamond J, Vieco A, Chaudhuri S, Shinnar E, Cromer S, Perel P, Mensah GA, Narula J, Johnson CO, Roth GA, Moran AE.

Glob Heart. 2018 Sep;13(3):143-163. doi: 10.1016/j.gheart.2018.09.511. Epub 2018 Oct 6. No abstract available. Erratum in: Glob Heart. 2019 Mar;14(1):97.

PMID:
30301680
18.

Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings.

Jindal D, Gupta P, Jha D, Ajay VS, Goenka S, Jacob P, Mehrotra K, Perel P, Nyong J, Roy A, Tandon N, Prabhakaran D, Patel V.

Glob Health Action. 2018;11(1):1517930. doi: 10.1080/16549716.2018.1517930.

19.

Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.

Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L.

Prim Care Diabetes. 2018 Dec;12(6):517-525. doi: 10.1016/j.pcd.2018.07.015. Epub 2018 Aug 18.

20.

The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review.

Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P.

BMC Public Health. 2018 Aug 6;18(1):975. doi: 10.1186/s12889-018-5806-x.

21.

Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.

Palmer MJ, Barnard S, Perel P, Free C.

Cochrane Database Syst Rev. 2018 Jun 22;6:CD012675. doi: 10.1002/14651858.CD012675.pub2. Review.

22.

Cochrane corner: text messaging to improve adherence to drugs for secondary prevention of cardiovascular disease.

Adler AJ, Casas JP, Martin N, Free C, Perel P.

Heart. 2018 Nov;104(22):1814-1816. doi: 10.1136/heartjnl-2017-312888. Epub 2018 May 14. No abstract available.

PMID:
29760242
23.

Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review.

Ong SE, Koh JJK, Toh SES, Chia KS, Balabanova D, McKee M, Perel P, Legido-Quigley H.

PLoS One. 2018 Mar 29;13(3):e0195086. doi: 10.1371/journal.pone.0195086. eCollection 2018. Review.

24.

Improving medication adherence in patients with cardiovascular disease: a systematic review.

Fuller RH, Perel P, Navarro-Ruan T, Nieuwlaat R, Haynes RB, Huffman MD.

Heart. 2018 Aug;104(15):1238-1243. doi: 10.1136/heartjnl-2017-312571. Epub 2018 Mar 23.

PMID:
29572248
25.

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study.

Murphy A, Palafox B, O'Donnell O, Stuckler D, Perel P, AlHabib KF, Avezum A, Bai X, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Dans AL, Diaz R, Erbakan AN, Ismail N, Iqbal R, Kelishadi R, Khatib R, Lanas F, Lear SA, Li W, Liu J, Lopez-Jaramillo P, Mohan V, Monsef N, Mony PK, Puoane T, Rangarajan S, Rosengren A, Schutte AE, Sintaha M, Teo KK, Wielgosz A, Yeates K, Yin L, Yusoff K, Zatońska K, Yusuf S, McKee M.

Lancet Glob Health. 2018 Mar;6(3):e292-e301. doi: 10.1016/S2214-109X(18)30031-7.

26.

The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: A systematic review of randomised controlled trials.

Palmer M, Sutherland J, Barnard S, Wynne A, Rezel E, Doel A, Grigsby-Duffy L, Edwards S, Russell S, Hotopf E, Perel P, Free C.

PLoS One. 2018 Jan 5;13(1):e0189801. doi: 10.1371/journal.pone.0189801. eCollection 2018. Review.

27.

The Development of mWellcare, an mHealth System for the Integrated Management of Hypertension and Diabetes in Primary Care.

Jindal D, Gupta P, Jha D, Ajay VS, Jacob P, Mehrotra K, Perel P, Nyong J, Roy A, Tandon N, Prabhakaran D, Patel V.

Stud Health Technol Inform. 2017;245:1230.

PMID:
29295317
28.

Interventions and approaches to integrating HIV and mental health services: a systematic review.

Chuah FLH, Haldane VE, Cervero-Liceras F, Ong SE, Sigfrid LA, Murphy G, Watt N, Balabanova D, Hogarth S, Maimaris W, Otero L, Buse K, McKee M, Piot P, Perel P, Legido-Quigley H.

Health Policy Plan. 2017 Nov 1;32(suppl_4):iv27-iv47. doi: 10.1093/heapol/czw169. Review.

29.

EZSCAN for undiagnosed type 2 diabetes mellitus: A systematic review and meta-analysis.

Bernabe-Ortiz A, Ruiz-Alejos A, Miranda JJ, Mathur R, Perel P, Smeeth L.

PLoS One. 2017 Oct 30;12(10):e0187297. doi: 10.1371/journal.pone.0187297. eCollection 2017. Review.

30.

Roadmap to Achieve 25% Hypertension Control in Africa by 2025.

Dzudie A, Rayner B, Ojji D, Schutte AE, Twagirumukiza M, Damasceno A, Ba SA, Kane A, Kramoh E, Anzouan Kacou JB, Onwubere B, Cornick R, Sliwa K, Anisiuba B, Mocumbi AO, Ogola E, Awad M, Nel G, Otieno H, Toure AI, Kingue S, Kengne AP, Perel P, Adler A, Poulter N, Mayosi B; PASCAR Task Force on Hypertension.

Glob Heart. 2018 Mar;13(1):45-59. doi: 10.1016/j.gheart.2017.06.001. Epub 2017 Oct 16.

PMID:
29042191
31.

Challenges and Opportunities to Scale Up Cardiovascular Disease Secondary Prevention in Latin America and the Caribbean.

Avezum Á, Perel P, Oliveira GBF, Lopez-Jaramillo P, Restrepo G, Loustalot F, Srur A, de La Noval R, Connell KI, Cruz-Flores S, de Moura L, Castellac G, Mattos AC, Ordunez P.

Glob Heart. 2018 Jun;13(2):83-91. doi: 10.1016/j.gheart.2017.05.002. Epub 2017 Oct 9. Review. No abstract available.

PMID:
29032937
32.

WHF Emerging Leaders Program.

Huffman MD, Perel P, Eisele JL, Labarthe DR, Wood DA, Sliwa K, Yusuf S.

Eur Heart J. 2017 Oct 1;38(37):2800-2803. doi: 10.1093/eurheartj/ehx483. No abstract available.

PMID:
28982234
33.

Roadmap to achieve 25% hypertension control in Africa by 2025.

Dzudie A, Rayner B, Ojji D, Schutte AE, Twagirumukiza M, Damasceno A, Ba SA, Kane A, Kramoh E, Kacou JB, Onwubere B, Cornick R, Sliwa K, Anisiuba B, Mocumbi AO, Ogola E, Awad M, Nel G, Otieno H, Toure AI, Kingue S, Kengne AP, Perel P, Adler A, Poulter N, Mayosi B; PASCAR task force on hypertension.

Cardiovasc J Afr. 2017 Jul/Aug;28(4):262-272. doi: 10.5830/CVJA-2017-040. Review.

34.

Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India.

Jha D, Gupta P, Ajay VS, Jindal D, Perel P, Prieto-Merino D, Jacob P, Nyong J, Venugopal V, Singh K, Goenka S, Roy A, Tandon N, Patel V, Prabhakaran D.

BMJ Open. 2017 Aug 11;7(8):e014851. doi: 10.1136/bmjopen-2016-014851.

35.

World Heart Federation Cholesterol Roadmap.

Murphy A, Faria-Neto JR, Al-Rasadi K, Blom D, Catapano A, Cuevas A, Lopez-Jimenez F, Perel P, Santos R, Sniderman A, Sy R, Watts GF, Zhao D, Yusuf S, Wood D.

Glob Heart. 2017 Sep;12(3):179-197.e5. doi: 10.1016/j.gheart.2017.03.002. Epub 2017 Jul 29. Review.

PMID:
28765036
36.

Integrating cervical cancer with HIV healthcare services: A systematic review.

Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, Watt N, Alvaro A, Otero-Garcia L, Balabanova D, Hogarth S, Maimaris W, Buse K, Mckee M, Piot P, Perel P, Legido-Quigley H.

PLoS One. 2017 Jul 21;12(7):e0181156. doi: 10.1371/journal.pone.0181156. eCollection 2017. Review.

37.

Integrating HIV and substance use services: a systematic review.

Haldane V, Cervero-Liceras F, Chuah FL, Ong SE, Murphy G, Sigfrid L, Watt N, Balabanova D, Hogarth S, Maimaris W, Buse K, Piot P, McKee M, Perel P, Legido-Quigley H.

J Int AIDS Soc. 2017 May 30;20(1):21585. doi: 10.7448/IAS.20.1.21585. Review.

38.

Integrating cardiovascular diseases, hypertension, and diabetes with HIV services: a systematic review.

Haldane V, Legido-Quigley H, Chuah FLH, Sigfrid L, Murphy G, Ong SE, Cervero-Liceras F, Watt N, Balabanova D, Hogarth S, Maimaris W, Buse K, McKee M, Piot P, Perel P.

AIDS Care. 2018 Jan;30(1):103-115. doi: 10.1080/09540121.2017.1344350. Epub 2017 Jul 5. Review.

PMID:
28679283
39.

Health systems facilitators and barriers to the integration of HIV and chronic disease services: a systematic review.

Watt N, Sigfrid L, Legido-Quigley H, Hogarth S, Maimaris W, Otero-García L, Perel P, Buse K, McKee M, Piot P, Balabanova D.

Health Policy Plan. 2017 Nov 1;32(suppl_4):iv13-iv26. doi: 10.1093/heapol/czw149. Review.

40.

Diabetes care in a complex humanitarian emergency setting: a qualitative evaluation.

Murphy A, Biringanine M, Roberts B, Stringer B, Perel P, Jobanputra K.

BMC Health Serv Res. 2017 Jun 23;17(1):431. doi: 10.1186/s12913-017-2362-5.

41.

Atrial fibrillation: the current epidemic.

Morillo CA, Banerjee A, Perel P, Wood D, Jouven X.

J Geriatr Cardiol. 2017 Mar;14(3):195-203. doi: 10.11909/j.issn.1671-5411.2017.03.011. Review.

42.

Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.

Adler AJ, Martin N, Mariani J, Tajer CD, Owolabi OO, Free C, Serrano NC, Casas JP, Perel P.

Cochrane Database Syst Rev. 2017 Apr 29;4:CD011851. doi: 10.1002/14651858.CD011851.pub2. Review.

43.

Evaluation of a community-based hypertension improvement program (ComHIP) in Ghana: data from a baseline survey.

Lamptey P, Laar A, Adler AJ, Dirks R, Caldwell A, Prieto-Merino D, Aerts A, Pearce N, Perel P.

BMC Public Health. 2017 Apr 28;17(1):368. doi: 10.1186/s12889-017-4260-5.

44.

Prognosis of undiagnosed chest pain: linked electronic health record cohort study.

Jordan KP, Timmis A, Croft P, van der Windt DA, Denaxas S, González-Izquierdo A, Hayward RA, Perel P, Hemingway H.

BMJ. 2017 Apr 3;357:j1194. doi: 10.1136/bmj.j1194.

45.

The World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation.

Murphy A, Banerjee A, Breithardt G, Camm AJ, Commerford P, Freedman B, Gonzalez-Hermosillo JA, Halperin JL, Lau CP, Perel P, Xavier D, Wood D, Jouven X, Morillo CA.

Glob Heart. 2017 Dec;12(4):273-284. doi: 10.1016/j.gheart.2017.01.015. Epub 2017 Mar 21. Review.

46.

Uses of polypills for cardiovascular disease and evidence to date.

Huffman MD, Xavier D, Perel P.

Lancet. 2017 Mar 11;389(10073):1055-1065. doi: 10.1016/S0140-6736(17)30553-6. Review.

PMID:
28290995
47.

Risk scoring for the primary prevention of cardiovascular disease.

Karmali KN, Persell SD, Perel P, Lloyd-Jones DM, Berendsen MA, Huffman MD.

Cochrane Database Syst Rev. 2017 Mar 14;3:CD006887. doi: 10.1002/14651858.CD006887.pub4. Review.

48.

Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.

Allan V, Honarbakhsh S, Casas JP, Wallace J, Hunter R, Schilling R, Perel P, Morley K, Banerjee A, Hemingway H.

Thromb Haemost. 2017 May 3;117(5):837-850. doi: 10.1160/TH16-11-0825. Epub 2017 Feb 23. Review.

49.

Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries.

Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, Ismail N, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Diaz R, Gupta R, Iqbal R, Kaur M, Khatib R, Kruger A, Kruger IM, Lanas F, Lopez-Jaramillo P, Minfan F, Mohan V, Mony PK, Oguz A, Palileo-Villanueva LM, Perel P, Poirier P, Rangarajan S, Rensheng L, Rosengren A, Soman B, Stuckler D, Subramanian SV, Teo K, Tsolekile LP, Wielgosz A, Yaguang P, Yeates K, Yongzhen M, Yusoff K, Yusuf R, Yusufali A, Zatońska K, Yusuf S.

Int J Equity Health. 2016 Dec 8;15(1):199.

50.

Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.

Nyong J, Amit G, Adler AJ, Owolabi OO, Perel P, Prieto-Merino D, Lambiase P, Casas JP, Morillo CA.

Cochrane Database Syst Rev. 2016 Nov 22;11:CD012088. Review.

Supplemental Content

Support Center